Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases

Medtech Insight spoke to David Atkins, the CEO of genomics company Congenica, to learn more about how its platform is being used in one of the largest genetics studies to date. The company expects the technology to eventually transform treatment of rare diseases.

• Source: Alamy

The field of diagnostics has come a long way in recent years, and the COVID-19 pandemic has highlighted the industry's advancement with the rapid deployment of highly accurate, rapid, and affordable testing kits proving its abilities. 

But to diagnose a disease, you need to know what you are looking for. This is not an issue for...

More from Diagnostics

More from Device Area